Quantbot Technologies LP Beam Therapeutics Inc. Transaction History

Quantbot Technologies LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$23.46 - $45.07 $65,688 - $126,196	2,800 New	2,800 $92,000
Q2 2023 Aug 08, 2023	BUY	$29.32 - $35.99 $99,688 - $122,366	3,400 New	3,400 $108,000
Q4 2022 Feb 13, 2023	BUY	$36.73 - $51.6 $179,389 - $252,014	4,884 Added 1580.58%	5,193 $203,000
Q3 2022 Nov 07, 2022	SELL	$39.79 - $70.31 $437,331 - $772,777	-10,991 Reduced 97.27%	309 $14,000
Q2 2022 Aug 09, 2022	SELL	$29.86 - $62.36 $28,695 - $59,927	-961 Reduced 7.84%	11,300 $437,000
Q1 2022 May 16, 2022	BUY	$53.73 - $82.16 $622,354 - $951,659	11,583 Added 1708.41%	12,261 $702,000
Q4 2021 Feb 11, 2022	SELL	$68.02 - $99.06 $184,810 - $269,146	-2,717 Reduced 80.03%	678 $54,000
Q3 2021 Nov 09, 2021	BUY	$84.37 - $133.6 $286,436 - $453,572	3,395 New	3,395 $295,000

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.